Last $7.20 USD
Change Today +0.17 / 2.42%
Volume 1.5M
AFFX On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

affymetrix inc (AFFX) Snapshot

Open
$7.00
Previous Close
$7.03
Day High
$7.28
Day Low
$7.00
52 Week High
01/21/14 - $9.80
52 Week Low
05/2/13 - $3.22
Market Cap
521.9M
Average Volume 10 Days
1.4M
EPS TTM
$-0.39
Shares Outstanding
72.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AFFYMETRIX INC (AFFX)

affymetrix inc (AFFX) Related Businessweek News

No Related Businessweek News Found

affymetrix inc (AFFX) Details

Affymetrix, Inc. provides life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein, and cell level primarily in the United States, Europe, Latin America, and Asia. The company operates in two segments, Affymetrix Core and eBioscience. The Affymetrix Core segment is engaged in the development, manufacture, and commercialization of systems for genetic analysis in the life sciences and diagnostic industry. This segment develops and markets GeneChip gene expression products and services; genotyping product line, such as the Axiom product line; arrays and assays with clinical research applications, such as the CytoScan and OncoScan products; QuantiGene line of singleplex and multiplex assays to serve customers in the research and translational medicine markets; and GeneTitan family of products consisting of the GeneTitan instrument system that runs genotyping and gene expression array plates. It also offers life science reagents, such as ExoSAP-IT for a reagent for the clean-up of polymerase chain reaction, and HotStart-IT reagents to inhibit primer dimer formation; enzymes; purification kits; and biochemicals for life science researchers. The eBioscience segment is involved in the development, manufacturing, marketing, and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging, and other protein-based analyses. This segment offers a portfolio of antibodies and reagents, as well as a range of the QuantiGene and Procarta assay portfolio. The company sells its products directly and through third party distributors to genomic research centers, academic institutions, government, and private laboratories, as well as pharmaceutical, diagnostic, and biotechnology companies. Affymetrix, Inc. was founded in 1991 and is headquartered in Santa Clara, California.

1,100 Employees
Last Reported Date: 03/3/14
Founded in 1991

affymetrix inc (AFFX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $529.0K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $412.9K
Compensation as of Fiscal Year 2012.

affymetrix inc (AFFX) Key Developments

Affymetrix Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013; Provides Earnings Outlook for the Year 2014

Affymetrix Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2013. For the quarter, the company's total revenue was $92,636,000 compared to $84,349,000 a year ago. Pro forma revenue was $87,336. Income from operations was $3,890,000 compared to loss from operations of $9,233,000 a year ago. Income before income taxes was $9,049,000 compared to loss before income taxes of $10,868,000 a year ago. Net income was $9,373,000 or $0.10 per diluted share compared to net loss of $12,269,000 or $0.17 per diluted share a year ago. Non-GAAP net income was $2,223,000 or $0.02 per diluted share compared to $1,332,000 or $0.02 per diluted share a year ago. Capital expenditure in the fourth quarter was approximately $1.8 million. Non-GAAP operating income was $2.2 million and the improvement of $3.5 million over the prior year. For the year, the company's total revenue was $330,399,000 compared to $295,623,000 a year ago. Pro forma revenue was $325,099. Loss from operations was $12,552,000 compared to $39,091,000 a year ago. Loss before income taxes was $15,166,000 compared to $46,549,000 a year ago. Net loss was $16,327,000 or $0.23 per diluted share compared to $10,696,000 or $0.15 per diluted share a year ago. Non-GAAP net income was $7,426,000 or $0.10 per diluted share compared to non GAAP net loss of $6,763,000 or $0.10 per diluted share a year ago. Positive cash flow from operation of $65.4 million. Net debt payments made during the year were $33.8 million. For the year 2014, the company expects to generate topline revenue of approximately $335 million. The company expects to generate EBITDA in the range of 12% to 13%.

Affymetrix Inc. Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-13-2014 08:05 AM

Affymetrix Inc. Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-13-2014 08:05 AM. Venue: The Waldorf Astoria Hotel, New York, New York, United States. Speakers: Franklin R. Witney, Chief Executive Officer, President and Director, Gavin Wood, Chief Financial Officer and Executive Vice President.

Affymetrix Inc. Presents at Cowen & Co. 34th Annual Health Care Conference, Mar-04-2014 11:20 AM

Affymetrix Inc. Presents at Cowen & Co. 34th Annual Health Care Conference, Mar-04-2014 11:20 AM. Venue: Marriott Copley Place Hotel, Boston, Massachusetts, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AFFX:US $7.20 USD +0.17

AFFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Enzo Biochem Inc $4.29 USD -0.02
Luminex Corp $17.36 USD +0.08
NanoString Technologies Inc $16.67 USD +0.70
Pacific Biosciences of California Inc $4.39 USD -0.11
Sequenom Inc $2.59 USD 0.00
View Industry Companies
 

Industry Analysis

AFFX

Industry Average

Valuation AFFX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AFFYMETRIX INC, please visit www.affymetrix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.